Biotalys, a pioneering crop protection company based in Ghent, Belgium, has successfully raised €15 million to further enhance its transformative protein-based biocontrol solutions. Founded in 2013 as a spin-off from the renowned VIB (Flanders Institute for Biotechnology), Biotalys is dedicated to reshaping the future of sustainable food supply through innovative agricultural practices. This latest funding round is a significant milestone for the company as it accelerates the development of its groundbreaking technology platform, aimed at addressing the critical challenges posed by crop pests and diseases across the entire agricultural value chain—from soil to plate. Biotalys is on the verge of launching its first biofungicide, EVOCA, in the United States and Europe, subject to regulatory approval. The funds raised will be instrumental in advancing this product to market, alongside expanding the company's product pipeline, which features a diverse range of effective and safe biocontrol solutions with novel modes of action. By harmonizing the high-performance characteristics of chemical solutions with the environmentally friendly attributes of biological agents, Biotalys positions itself at the forefront of sustainable agriculture. This funding not only reinforces investor confidence in Biotalys' mission but also underscores the increasing demand for safer, eco-friendly crop protection options in an industry that is rapidly evolving towards sustainability. With its commitment to innovation and safety, Biotalys is set to play a pivotal role in transforming agricultural practices and ensuring a secure food supply for future generations. For more information about Biotalys and its initiatives, please visit www.biotalys.com.






